跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 6,886 条关于
“SNP-630-MS”
全部
6,886
临床试验
4,487
药物
1,228
机构
44
资讯
1,127
去年
SNP-630-MS Shows Promise in Mitigating MASH in Preclinical and Phase 2 Studies
去年
Genetic Factors Drive Early B Cell Repletion After Anti-CD20 Therapy in African American MS Patients
2年前
Merck Discontinues Phase 3 Trials of Pembrolizumab in NSCLC and CSCC
去年
Ocrevus Zenovo Offers New Hope for MS Patients with Shorter Infusion Times
去年
Octave's MSDA Test Transforms MS Care with Biomarker-Driven Insights
去年
Real-World Discontinuations of Ocrelizumab in MS Comparable to Pivotal Trials
去年
Phase 1 Trial of Lucid-MS Initiated to Protect Myelin Sheath in Multiple Sclerosis
上个月
Gut-Derived Regulatory B Cells May Explain Efficacy of MS Immunotherapy
去年
Sanofi Announces Breakthroughs in Multiple Myeloma and MS Treatments
去年
High Cholesterol Levels Linked to Cognitive Impairment in Multiple Sclerosis
第 1 页,共 113 页
上一页
下一页